GEMMA Biotherapeutics
PrivateLast Round
Grant
Jul 9, 2026
Total Funding Raised
$34M
Company Overview
GEMMA Biotherapeutics is a biotechnology company that develops gene therapies for rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GEMMA Biotherapeutics Comparables
Compare GEMMA Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iECURE | 81% | |
| Capsida Biotherapeutics | 81% | |
| Passage Bio | 79% |
GEMMA Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2026 | ||||
| Seed | Dec 23, 2024 | ||||
| Strategic | Oct 8, 2024 |
Key People
Founding team and executive leadership
GEMMA Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bioluminescence Ventures | Seed |
| ARPA-H | Grant |
| Earlybird Venture Capital | Seed |
| Double Point Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Affiliation with Franklin Biolabs to translate scientific work into clinical trials.
- Mar 1, 2026
Gene therapy pioneer Jim Wilson appointed to lead the company.
GEMMA Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GEMMA Biotherapeutics's valuation, stock price, and market status.
Is GEMMA Biotherapeutics a public or private company?
GEMMA Biotherapeutics is a private company.
What is the current stock price of GEMMA Biotherapeutics?
GEMMA Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is GEMMA Biotherapeutics worth (valuation)?
Valuation information for GEMMA Biotherapeutics is not publicly available.
Can I buy GEMMA Biotherapeutics stock?
GEMMA Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GEMMA Biotherapeutics's last funding round?
GEMMA Biotherapeutics's most recent funding round was Seed on December 23, 2024.
Who are the main investors in GEMMA Biotherapeutics?
Key investors in GEMMA Biotherapeutics include Bioluminescence Ventures, Earlybird Venture Capital, Double Point Ventures.
Will GEMMA Biotherapeutics IPO soon?
No public IPO plans have been announced for GEMMA Biotherapeutics.
How can I track GEMMA Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GEMMA Biotherapeutics's secondary market activity and sign up for updates.